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Endoplasmic reticulum (ER)-associated degradation (ERAD) is a universally important
process among eukaryotic cells. ERAD is necessary to preserve cell integrity since
the accumulation of defective proteins results in diseases associated with neurological
dysfunction, cancer, and infections. This process involves recognition of misfolded or
misassembled proteins that have been translated in association with ER membranes.
Recognition of ERAD substrates leads to their extraction through the ER membrane
(retrotranslocation or dislocation), ubiquitination, and destruction by cytosolic proteasomes.
This review focuses on ERAD and its components as well as how viruses use this process
to promote their replication and to avoid the immune response.
Keywords: ERAD, immune response, retrotranslocation, ubiquitination, proteasomal degradation, retrovirus,
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INTRODUCTION
Although endoplasmic reticulum (ER)-associated degradation
(ERAD) has been most thoroughly deﬁned in yeast, recent studies
in higher organisms have revealed the conservation of this pro-
cess and its components. Multiple diseases, including Parkinson’s,
Alzheimer’s, cancer, and infectious processes, result from failure
of ERAD, conﬁrming its signiﬁcance for correct cell function. Pre-
dictably, viruses have exploited various aspects of this key cellular
machinery to further their propagation. Nonetheless, the com-
plexity of ERAD and the number of players involved necessitates a
review of its features prior to a description of how viruses have
manipulated ERAD to their advantage. In understanding how
viruses exploit ERAD, we learn more about the cellular process,
but also how we might alter the outcome of viral diseases.
THE ERAD PROCESS
A majority of newly synthesized proteins in mammalian cells are
either misfolded or misassembled (Hoseki et al., 2010). Approx-
imately 30% of new proteins are synthesized in association with
the ER (Brodsky and Wojcikiewicz, 2009). The ER quality con-
trol system both senses and disposes of terminally misfolded
proteins by ERAD, a process that is conserved in eukaryotes
(Vembar and Brodsky, 2008; Merulla et al., 2013). This process
detects misfolded proteins in the ER lumen, and then extracts
them through membrane channels in an energy-dependent man-
ner for delivery to cytosolic proteasomes (Olzmann et al., 2013).
Protein extraction through ER membrane channels is known as
dislocation or retrotranslocation (Hampton and Sommer, 2012).
Because protein folding depends on multiple cellular compo-
nents (Merulla et al., 2013), protein overexpression or the presence
of mutant proteins may sequester limiting components, lead-
ing to accumulation of misfolded proteins in the ER lumen. A
more general failure of the ERAD process may occur if pro-
teins are unable to fold within a reasonable time, resulting in
inefﬁcient retrotranslocation and proteasomal degradation. Levels
of ERAD-associated factors also may be affected by the intralumi-
nal concentration of misfolded proteins. Inability of the ERAD
system to destroy misfolded proteins is associated with more
than 60 diseases, including neurological illnesses (Alzheimer’s
and Parkinson’s), cystic ﬁbrosis, infectious diseases, diabetes,
and cancer (Guerriero and Brodsky, 2012). Particularly rele-
vant to the subject of this review, viruses can produce large
quantities of glycoproteins in a short period of time, which
may overwhelm ERAD, leading to the accumulation of mis-
folded proteins, cell death, and associated pathology (Franz et al.,
2014).
Although ERAD is vital to the maintenance of healthy cells,
many parts of this process are not well characterized. Multiple
aspects of ERAD have been described in yeast (Thibault and Ng,
2012), including the nature of the ER channel and the components
needed to identify misfolded proteins during and after translation.
Protein translocation across the ER membrane is the prerequisite
for ERAD. Translation of many transmembrane proteins involves
recognition of a hydrophobic signal peptide (SP) emerging from
the ribosome by signal recognition particle (SRP), which is associ-
ated with the trimeric Sec61 complex. Many of the SPs are cleaved
by signal peptidase, which is associatedwith the luminal side of the
translocon (Auclair et al., 2012). The Sec61 complex provides the
aqueous channel for co-translational transfer of proteins across
the ER membrane (Loibl et al., 2014).
Recent evidence indicates that translocation across the ER
membrane can occur through an SRP-independent process
(Denic, 2012; Johnson et al., 2013). Based on recent experiments
in yeast, more than 40% of signal-containing proteins fail to use
SRP, including tail-anchored (TA) proteins and short secretory
proteins (Johnson et al., 2012; Ast et al., 2013). Instead, these pro-
teins are targeted by the GET pathway to the Sec61 translocon
that is associated with the Sec 62/63 complex rather than through
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docking to the SRP receptor (Rapoport, 2007; Ast et al., 2013).
One large class of SRP-independent proteins includes the glyco-
sylphosphatidylinositol (GPI)-anchored proteins, which contain
both an N-terminal signal sequence and a C-terminal GPI anchor
(Ast et al., 2013). This N-terminal signal is less hydrophobic than
typical SRP targets. Furthermore, the Sec61 translocon has been
implicated as the channel for retrotranslocation (Kiser et al., 2001),
and it has been proposed that protein transfer can be either for-
ward or reverse with respect to the ER lumen (Johnson and Haigh,
2000). Therefore, Sec61 appears to complex with a number of dif-
ferent proteins, leading to a highly ﬂexible and dynamic structure,
where association with different proteins/protein complexes leads
to transit in or out of the ER (Figure 1).
SUBSTRATE RECOGNITION FOR ERAD
Reports in yeast indicate that proteins can be O-mannosylated
prior to N-glycosylation (Ecker et al., 2003), and both types of
glycosylation are believed to occur co-translationally (Loibl et al.,
2014). These glycosylases also have been shown to be associated
with the translocon (Chavan and Lennarz, 2006), and experi-
ments indicate competition for different glycosylation sites (Loibl
et al., 2014). The protein O-mannosyl transferases (PMTs) and the
oligosaccharyltransferases (OSTs) are transmembrane proteins,
but the latter catalyzes addition of oligosaccharides to nascent
polypeptides on asparagine residues (Breitling and Aebi, 2013).
The OSTs prefer NxT/S sequences in an unfolded or ﬂexible pro-
tein domain, and the unfolded state may be facilitated by the
OST complex associated with the translocon (Breitling and Aebi,
2013). Glycosylation near the C-terminal end of the protein is less
efﬁcient, perhaps due to competition between OSTs and protein
folding (Ben-Dor et al., 2004; Breitling and Aebi, 2013). PMTs
also are essential for ERAD in yeast. A pmt mutant showed
increased degradation of a typical ERAD substrate (Arroyo et al.,
2011). Moreover, addition of oligosaccharides can be prevented
by nearby cysteines and disulﬁde bond formation (Allen et al.,
1995). Thus, glycosylation is one determinant of the correct
folding of a protein in the ER lumen (Breitling and Aebi, 2013;
Figure 1A).
The oligosaccharides on ER luminal proteins are critical
for their correct folding or selection for ERAD. The nascent
N-glycosylated protein has a three-branch structurewith glucose3-
mannose9-N-acetylglucosamine2-asparagine (Aebi et al., 2010;
Merulla et al., 2013). Trimming of the ﬁrst two glucose residues
on one branch then allows interactions with two ER-resident
chaperone/lectin proteins, calnexin and calreticulin, which may
lead to protein folding (Brodsky, 2012). Removal of the third
glucose causes release from these lectins and exit from the ER
(Smith et al., 2011; Olzmann et al., 2013), but re-addition of this
glucose by UDP-glucose:glycoprotein glucosyltransferase allows
reassociation (Shenkman et al., 2013). Proteins retry folding
until removal of three or four mannose residues triggers ERAD
(Lederkremer and Glickman, 2005; Shenkman et al., 2013). Cor-
rectly folded proteins leave the ER after one or two mannose
residues have been cleaved (Shenkman et al., 2013). Mannose
removal is achieved using ER mannosidase I (ERmanI), the ER
degradation-enhancing α-mannosidase-like proteins (EDEMs)
and/or the Golgi-resident protein Man1C1 (Gonzalez et al.,
1999; Hirao et al., 2006; Olivari et al., 2006; Hosokawa et al.,
2007). Several lectins, OS-9 and XTP3-B, then interact via
their MRH domains with the mannose-trimmed proteins, allow-
ing their association with the retrotranslocon (Bernasconi et al.,
2008; Christianson et al., 2008; Hosokawa et al., 2008). OS-
9 and XTP3-B also associate with different proteases, LONP2
and carboxypeptidase vitellogenic-like protein (CPVL), respec-
tively, suggesting that some substrates may be partially degraded
prior to dislocation (Christianson et al., 2012; Olzmann et al.,
2013). Nonetheless, multiple attempts are made to refold pro-
teins before their triage through ERAD. The role of chaperones
includes recognition of inappropriate glycosylation as well as
refolding efforts, but proteins delivered to the retrotranslocon
may require unfolding and partial proteolysis to allow their
transit through the narrow membrane channel (Gogala et al.,
2014).
Non-glycosylated proteins canbe subjected toERAD,but detec-
tion of misfolding of these proteins does not involve calnexin
and calreticulin (Brodsky, 2012). Notably, the non-lectin chap-
erone BiP is involved in ERAD targeting of both types of proteins
(Ushioda et al., 2013), yet also serves to prevent leakage of calcium
out of the ER lumen (Schäuble et al., 2012). In addition, targeting
of unglycosylated proteins to the proteasomes involves EDEM1
(Shenkman et al., 2013), which, like BiP, recognizes misfolded gly-
coproteins, as well as the transmembrane Herp protein (Usa1p in
yeast; Okuda-Shimizu and Hendershot, 2007). Both glycosylated
and their non-glycosylated derivatives are recruited to the ER-
derived quality control compartment (ERQC) near the nucleus in
the presence of a proteasomal inhibitor (Shenkman et al., 2013).
Thus, these studies suggest that targeting of misfolded proteins for
ERAD is similar for glycoproteins and non-glycosylated proteins
(Shenkman et al., 2013).
Interaction of lectin-type and other chaperones with ERAD
substrates allows association with members of the protein disul-
ﬁde isomerase (PDI) family, which generally are characterized by
one or more thioredoxin-like motifs (CXXC; Brodsky and Skach,
2011). Interestingly, these proteins can form, break, or rearrange
disulﬁde bonds as well as act as chaperones (Benham, 2012). The
yeast PDI family is composed of ﬁvemembers (Pdi1,Mpd1,Mpd2,
Eug1, and Eps1), although only Pdi1 is essential (Farquhar et al.,
1991). In mammalian cells, PDI is one of the best characterized
family members, but there are at least 21 such enzymes (Benham,
2012; Grubb et al., 2012). PDI family proteins are generally con-
ﬁned by a KDEL retention sequence (Benham, 2012) to the ER,
which has an oxidizing environment (Costantini et al., 2013). The
oxidoreductase ERp57, which is localized near the ER-Golgi inter-
mediate compartment (ERGIC),may provide some protection for
proteins that might be routed for ERAD by calnexin (Frenkel et al.,
2004). In addition, some PDI members can escape the secretory
system and appear at the cell surface (Benham, 2012). For exam-
ple, a disintegrin and metalloproteinase (ADAM17; also known
as tumor necrosis factor alpha-converting enzyme or TACE) has
been shown to be regulated by an extracellular activity of PDI
(Bass and Edwards, 2010; Willems et al., 2010; Düsterhöft et al.,
2013). PDI members also have a role in ERAD, with different
requirements for different substrates (Grubb et al., 2012). In hep-
atic cells, PDI promotes the folding of apolipoprotein B (ApoB)
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FIGURE 1 |The ERAD process. (A) Substrate recognition. Many nascent
polypeptides (curved line) have one or more high-mannose carbohydrates
(shown as a branched structure), which must be recognized and processed in
a timely manner to allow exit from the ER. Binding of these ER-luminal
proteins to substrates is affected by folding to their native conformations.
Folding involves formation and breakage of disulﬁde bonds by members of
the PDI family, such as ERp57 and ERp72, and is facilitated by chaperone
proteins, such as BiP. Speciﬁc carbohydrates are bound by different
chaperones/lectins in the ER lumen. These proteins include ERManI, EDEM,
OS-9, XTP3-B, calreticulin, and calnexin. Recognition of ERAD substrates
probably results in assembly of the retrotranslocon (shown here as Herp and
the translocon/BiP complex). Herp is thought to facilitate oligomerization of
the Hrd1 E3 ligase. BiP binds to a number of glycosylated and
non-glycosylated ERAD substrates and provides a barrier on the ER luminal
side of the translocon. (B) Retrotranslocation. Recognition of misfolded or
misassembled proteins triggers the assembly of the retrotranslocon. Current
evidence indicates that multiple types of retrotranslocons are possible (see
text). A typical retrotranslocon/dislocon is shown containing Derlin, the E3
ligase Hrd1 and its partner Sel1L, which then recruits the cytosolic ATPase
p97. Derlin has 6 transmembrane domains with both the N-terminus and
C-terminus in the cytosol. Presumably some or all of the recognition
components, such as PDI and ERManI, disengage as the substrate passes
through the translocon. All retrotranslocation events appear to involve p97.
The retrotranslocon is shown with BiP opening the Sec61 channel for
substrate passage into the cytosol. (C) Ubiquitination of ERAD substrates.
Retrotranslocation exposes ERAD substrates to cytosolic E1 (unknown), E2
(shown here as Ube2g1), and E3 enzymes (e.g., Hrd1). A polyubiquitin chain
is produced as the substrate is engaged by the E2 and E3 proteins. Multiple
E3s may be responsible for the polyubiquitin chains that then bind to the p97
partner proteins, Ufd1 and Npl4. The substrate is shown moving through the
translocon into the center of the p97 hexamer. (D) Proteasomal degradation.
Once the substrate has been retrotranslocated, the BiP protein seals the
luminal side of the translocon. The retrotranslocon may then be disassembled
prior to engagement of a new substrate. The retrotranslocated proteins must
be modiﬁed by removal of carbohydrate and ubiquitin chains for insertion into
the narrow channel of the proteasome. It is possible that p97 substitutes for
the 19S lid, which provides access to the proteasome channel and the energy
for unfolding of substrates. Degraded polypeptides are shown emerging from
the 19S lid. This model suggests that there are retrotranslocon-speciﬁc
proteasomes.
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through its chaperone activity, whereas ERp57 or ERp72 expres-
sion leads to ERAD (Grubb et al., 2012). Further, various cell types
express different PDI proteins, allowing differential regulation of
substrates (Benham, 2012; Pescatore et al., 2012) and, presumably,
their ERAD targeting.
Protein folding involves both formation of disulﬁde bonds
and cis/trans isomerization of peptide bonds preceding proline
residues (Hebert and Molinari, 2007). Certain ERAD substrates
appear to be dependent on proline isomerization (Bernasconi
et al., 2010b), and such refolding events may be necessary for tran-
sit through the retranslocon by elimination of turns in substrate
secondary structure (Määttänen et al., 2010). ERAD require-
ments for peptidyl-prolyl cis/trans isomerases (PPIs) depend on
whether the substrate is strictly in the ER lumen or is tethered
to the ER membrane (Bernasconi et al., 2010b). The PPI protein
cyclophilin B was needed for ERAD of a luminal target, but not
the same target with a transmembrane domain (Bernasconi et al.,
2010b). Requirement for PPIs during ERAD may depend on pro-
line residues in the cis conﬁguration (Bernasconi et al., 2010b),
potentially by conversion into trans peptidyl–prolyl bonds, thus
eliminating secondary structures that hinder retrotranslocation
(Määttänen et al., 2010).
RETROTRANSLOCATION
Mammalian cells have ERAD factors that are not present in
yeast. As observed for other pathways (Tsai and Weissman, 2012),
ERAD components identiﬁed in yeast have multiple family mem-
bers in higher eukaryotes; e.g., instead of a single Derlin in
yeast (Der1p), mammalian cells have three proteins (Derlin-1,
-2, and -3; Oda et al., 2006). Derlins are multiple membrane-
spanning domain proteins that have been proposed to be part
of the retrotranslocon channel (Ye et al., 2005) and/or regula-
tory factors for retrotranslocation (Brodsky, 2012; Figure 1B).
In addition, Derlin-3 has a cell-type speciﬁc distribution (Oda
et al., 2006), suggesting that recognition of certain substrates may
be involved in its function. Derlins are related to rhomboid pro-
teases, such as RHBDL4, which is an ER-resident transmembrane
protein that cleaves unstable single-membrane-spanning or poly-
topic membrane proteins (Fleig et al., 2012). RHBDL4 also is
upregulated by ER stress and binds to the cytosolic AAA ATPase
p97 (see below; Fleig et al., 2012). In contrast to the rhomboid
proteases, the Derlins lack proteolytic activity, suggesting that
these proteins bind to ERAD substrates and target them to E3
ligases for ubiquitination and to p97 for membrane extraction
(Brodsky, 2012). Cleavage of ERAD substrates by RHBDL4 (Fleig
et al., 2012), SP peptidase (SPP; Loureiro et al., 2006), or pro-
teases associated with OS-9 and XTP3-B (Olzmann et al., 2013)
may occur prior to retrotranslocation of some substrates (Tsai
and Weissman, 2012). On the other hand, it has been proposed
that Derlins form a six-transmembrane structure with a gate that
allows association and unfolding of substrates or access to other
retrotranslocon components, such as p97 (see below; Olzmann
et al., 2013). The p97 ATPase (Cdc48 in yeast) is bound to Derlin-
1 and Derlin-2 through their SHP domains (Greenblatt et al.,
2011).
Suppressor/enhancer of Lin12-like (SEL1L) appears to link
luminal factors that recognize misfolding and inappropriate
glycosylation, such as OS-9, XTP3-B, EDEMs, ERdj5, and the PDI
protein ERp90, to components of the retrotranslocon (Olzmann
et al., 2013;Williams et al., 2013). The transmembrane SEL1L pro-
tein (Hrd3p in yeast) also participates in regulation of ERAD by
sequestering EDEM1 and OS-9 into ER-derived vesicles known as
EDEMosomes (Bernasconi et al., 2012a). Inducible knockout of
Sel1L in mice leads to death of adult mice from acute pancreatic
atrophy (Sun et al., 2014). Sel1L expression is required for stabil-
ity of the E3 ligase hydroxymethylglutaryl reductase degradation
protein 1 (Hrd1), and its loss leads to ER stress and attenu-
ates translation, leading to cell death. Other proteins have been
described, such as Erlins 1 and 2 and TMUB1, which may act as
adapters between polytopic membrane substrates and E3 ligases
(Olzmann et al., 2013).
UBIQUITINATION
The ubiquitin ligases (E3s) have been proposed to be a struc-
tural part of the retrotranslocon channel (Brodsky, 2012), but
their role is considerably more complex (Figure 1C). Sev-
eral E3 ligases associated with ERAD are multiple membrane-
spanning proteins with cytosolic RING domains (Smith et al.,
2011; Ruggiano et al., 2014). In yeast, where ERAD has been stud-
ied most extensively, a prototypical transmembrane E3, such
as Hrd1p (also called SYVN1; Nadav et al., 2003; Kikkert et al.,
2004), can promote ERAD of a luminal substrate (ERAD-L).
The ERAD process also involves Hrd3p (SEL1L in metazoans)
as well as Usa1p and Der1p (Carvalho et al., 2010). Herp may
assist with Hrd1 oligomerization (Carvalho et al., 2010), Never-
theless, the other components appear to be dispensable if Hrd1p
is overexpressed, consistent with a role for Hrd1p in ERAD
substrate transfer across the membrane (Carvalho et al., 2010),
although such overexpression may be toxic due to inappropriate
protein degradation (Denic et al., 2006). Thus, protein adapters
appear to be necessary to achieve substrate speciﬁcity (Smith et al.,
2011).
Hrd1p-mediated ERAD requires oligomerization and trans-
membrane domains as well as ubiquitin ligase activity (Carvalho
et al., 2010). Overexpressionof a dominant-negativeRINGmutant
of the HRD1 ligase prevented ERAD of a non-glycosylated sub-
strate, but a dominant-negative Fbs2 mutant (a component of
SCF E3 ligases) did not (Shenkman et al., 2013). Dependence
on HRD1 also is affected by tethering of the substrate to the
ER membrane. Splice variants of the human beta-site amyloid
precursor cleaving enzyme (BACE) with the same deletion muta-
tion in the ectodomain are degraded through HRD1 if they are
luminal (ERAD-LS substrates), but disposal occurs in a HRD1-
independent manner if the variant has a transmembrane domain
(ERAD-LM substrates; Bernasconi et al., 2010a). Therefore, HRD1
recognizes substrates for ubiquitination and, perhaps,modiﬁes the
translocon in the ER membrane.
Multiple E3 ligases participate in ERAD. These ligases include
the transmembrane proteins gp78/AMFR (Fairbank et al., 2009),
TRC8 (Stagg et al., 2009), RMA1/RNF5 (El Khouri et al., 2013),
MARCH6/TEB4 (Doa10 in yeast; Kreft and Hochstrasser, 2011;
Olzmann et al., 2013), and CHIP (Matsumura et al., 2013). An
additional 40−50 membrane-spanning E3s may be involved in
ERAD (Stagg et al., 2009). Other E3 ligases associated with ERAD
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are localized to the cytosol, where they recognize misfolded gly-
coproteins that already have been retrotranslocated (Yoshida et al.,
2005; Shenkman et al., 2013). These ubiquitin ligases are members
of the cytosolic SCF (S-phase kinase-associated protein 1 (Skp1)-
Cullin 1 (Cul1)-F-box) family, where the F-box components of
the SCF complex recognize the N-glycans of the retrotranslocated
substrate, e.g., Fbs1 and Fbs2 (Yoshida, 2007). Furthermore, E3s
may work together to direct substrates for degradation (Olzmann
et al., 2013).
PROTEASOMAL DEGRADATION
The p97 protein (Cdc48 in yeast) is a member of the AAA ATPase
family (Erzberger and Berger, 2006) that functions during ERAD
in a complex with several cofactors that have a ubiquitin-X (UBX)
or UBX-like domain (Schuberth and Buchberger, 2008; Figure 1).
These cofactors include the heterodimer nuclear protein local-
ization homolog 4 (Npl4)–ubiquitin fusion degradation 1 (Ufd1;
Meyer et al., 2012; Wolf and Stolz, 2012), p47, UBXD1, UBXD7,
Ufd3/PLAA, VCIP135, and Ataxin-3 (Meyer et al., 2012). The
UFD1L and NPL4 proteins are believed to form a heterodimer,
where NPL4 is needed to stabilize UFD1L (Nowis et al., 2006).
The heterodimer acts as a substrate adapter to the p97 ATPase
associated with the retrotranslocon (Bays and Hampton, 2002).
UFD1L and NPL4 bind to K48-linked and K63-linked polyubiq-
uitin chains, respectively, which have been added by E3 ligases
associated with the retrotranslocon (Ye et al., 2003; Komander
et al., 2009).
In yeast, the Cdc48 ATPase binds to the Hrd1 E3 ligase
in a RING-dependent manner (Hampton and Sommer, 2012),
and the transmembrane Ubx2 (Sel1) protein acts as an adapter
using a UBA domain (Neuber et al., 2005; Schuberth and Buch-
berger, 2005). Several other ubiquitin ligases bind p97 directly
or through cofactors (Alexandru et al., 2008). The p97 cofac-
tors act as ubiquitin-binding proteins, although p97 also has
ubiquitin-binding activity (Ye et al., 2003; Meyer et al., 2012).
The adapter-p97 complexes may recognize different substrates
and perform independent functions, such as membrane protein
segregation and trafﬁcking, as well as directing substrates to the
proteasome (Ritz et al., 2011). Alternatively, other models sug-
gest that Derlins are involved in unfolding of substrates as well as
providing contacts with p97 and its associated factors (Greenblatt
et al., 2011). The p97ATPase binds ubiquitin chain editors that can
extend shorter chains as well as deubiquitinating enzymes (DUBs;
Jentsch and Rumpf, 2007; Sowa et al., 2009). Two ATPase domains
(D1 and D2; Meyer et al., 2012) within p97 form two stacked hex-
americ rings that provide the energy for protein remodeling and
substrate extraction from the membrane or through the retro-
translocon (Hampton and Sommer, 2012). Mutations in the D2
domain result in dominant-negative proteins that bind, but fail
to release, substrates (Pye et al., 2006). Mutant proteins have been
widely used to study p97 function in ERAD and its myriad other
activities (Meyer et al., 2012). Cytosolic chaperones, such asHsp70,
alsomay provide energy for extraction of membrane proteins with
misfolded cytoplasmic domains (ERAD-C substrates; Taxis et al.,
2003; Hrizo et al., 2007).
Once extraction from the ER membrane has occurred, p97
recruits peptide N-glycanase (PNGase) to cleave N-linked glycans
from glycosylated substrates (Hirsch et al., 2003; Li et al., 2006;
Figure 1D). In addition, p97 binds to a deubiquitinating enzyme
YOD1, presumably so that polyubiquitin chains will not interfere
with insertion into the proteasome (Ernst et al., 2009). The pro-
teasome is a highly complex structure with a 19S lid that has an
ATPase activity very similar to that of p97 (Lipson et al., 2008;
Matouschek and Finley, 2012). These enzymes may function syn-
ergistically to deliver substrates to the 20S core (Hampton and
Sommer, 2012). Alternatively, p97 may deliver certain substrates
directly to the proteasome core (Matouschek and Finley, 2012).
The proteasome core is composed of 28 subunits arranged into
four rings, each composed of seven subunits (Bhattacharyya et al.,
2014). Proteolytic activity is sequestered in the center of a narrow
chamber formed by the rings and, therefore, only unfolded pro-
teins can enter the chamber (Groll et al., 2000). The 19S lid, p97,
or other activators provide docking for substrates and substrate
modifying proteins as well as regulated opening of the chamber to
allow access of unfolded proteins for degradation in the 26S core
(Bhattacharyya et al., 2014).
Many questions remain about ERAD components and how
they identify and interact with different substrates. Similar to
our analysis of other cellular and molecular biological processes
through virology, studies of viruses that use ERAD are likely to
prove insightful.
VIRALMANIPULATION OF THE IMMUNE RESPONSE BY ERAD
The ability of viruses to cause persistent infections is a conse-
quence of downregulation or subversion of the immune response.
The herpesviruses are known to cause persistent infections. One
well-studied example of herpesvirus manipulation of the immune
response is reduced cell expression of major histocompatibility
complex class 1 (MHC-I) molecules by the viral proteins US2
and US11 (Wiertz et al., 1996). Both proteins are transmem-
brane glycoproteins and bind to newly made MHC-I to initiate
retrotranslocation. Despite their similar function, US2 and US11
use different pathways for MHC-I degradation (Figure 2). US2-
mediated degradation of MHC-I is independent of Derlin-1 and
involves SPP (Loureiro et al., 2006), which cleaves many SPs fol-
lowing their removal from nascent ER-bound pre-proteins (Voss
et al., 2013). Using an siRNA screen, TRC8 was identiﬁed as the
E3 ligase involved in MHC-I degradation by US2, but knockdown
of this transmembrane RING-type E3 had no effect on US11-
mediated destruction of MHC-I (Stagg et al., 2009). The US2
cytosolic tail interacts with SPP and the p97 ATPase (Chevalier
and Johnson, 2003; Loureiro et al., 2006), whereas TRC8 and US2
bind through their transmembrane domains (Stagg et al., 2009;
Figure 2A).
Unlike the Derlin-independent mechanism proposed for US2,
studies of the US11 protein facilitated identiﬁcation of Derlin-1
and SEL1L as ERAD components (Figure 1; Lilley and Ploegh,
2004; Ye et al., 2004; Mueller et al., 2006). US11 does not require
SPP for MHC-I degradation (Loureiro et al., 2006), but appears
to interact with the E3 ligase MARCHVII/axotrophin (Flierman
et al., 2006). The cytosolic domain of MHC-I is required for US11-
mediated ERAD targeting (Story et al., 1999; Barel et al., 2003),
and deletion of the C-terminal valine of MHC-I reduced inter-
action with Derlin-1 (Cho et al., 2013a). The ER luminal domain
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FIGURE 2 | MHC-I degradation by the herpesvirus US2 and US11
proteins. (A) Retrotranslocation of MHC-I by US2. US2 targets MHC-I
molecules for retrotranslocation by a process that requires signal peptide
peptidase (SPP), the E3 ligase TRC8, and the Ufd1-Npl4-p97 complex. SPP
may induce partial degradation of the substrate prior to its proteasomal
entry. (B) Retrotranslocation of MHC-I by US11. MHC-I is retrotranslocated
after US11 recruits SEL1L, Derlin-1, the E3 ligase MARCHVII, and p97. It is
not clear whether either degradation of MHC-I by US2 or US11 involves the
adapter complex Ufd1-Npl4, which recognizes different types of
polyubiquitin chains.
also affects degradation (Barel et al., 2003). In addition, MHC-
I substituted with the transmembrane domain of US11 caused
interactionwithDerlin-1 andproteasomal degradation (Cho et al.,
2013b). The p97 ATPase does not appear to interact directly with
MHC-I, but requires the interaction of MHC-I cytosolic domain
with the C-terminal domain of Derlin-1 (Cho et al., 2013a). Cho
et al. speculated that US11 recognizes MHC-I through its cytoso-
lic domain and transfers it to Derlin-1, which then interacts
with the p97 ATPase for membrane dislocation (Cho et al., 2013a;
Figure 2B). Therefore, studies of the herpesvirus US2 and US11
proteins revealed that the same substrate does not always use the
same ERAD pathway, and presumably these viral proteins act as
adapters that recognize different parts of MHC-I for targeting to
the dislocon.
Herpesviruses use another mechanism to decrease levels of
MHC-I. The mouse gammaherpesvirus 68 (MHV68) encodes an
E3 ligase (mK3) that ubiquitinates newly made MHC-I heavy
chains for proteasomal degradation (Boname and Stevenson,
2001). The mK3 ligase also is associated with the transporter-
associated with antigen processing (TAP) as well as p97 and
Derlin-1 (Wang et al., 2006). Polyubiquitination of MHC-I did
not require lysines (Wang et al., 2005), but could occur on ser-
ine and threonine residues in the heavy chain C-terminal tail
via the recruitment of the Ube2j2 E2 enzyme (see Figure 1;
Wang et al., 2007, 2009; Herr et al., 2009). These data indicate that
multiple ERAD mechanisms can be used by viruses to diminish
the adaptive immune response.
Like the herpesviruses, retroviruses also manipulate the
immune system through ERAD. Early studies indicated that
human immunodeﬁciency virus type 1 (HIV-1)-infected cells had
decreased levels of both CD4 mRNA and protein (Hoxie et al.,
1986). CD4 acts as the receptor for binding the viral envelope
(Env) protein (McClure et al., 1987). Furthermore, CD4 partici-
pates in T-cell activation by binding to both the T-cell receptor and
MHC class II molecules on antigen-presenting cells. CD4+ T cells
secrete cytokines that control antibody production, phagocytic
cell function, and cytotoxic T-cell responses, making them crucial
for adaptive immune responses (Tubo and Jenkins, 2014). HIV-1
encodes a number of accessory proteins, includingVpu, which are
not required for virus replication in tissue culture, but contribute
to viral pathogenesis (Strebel, 2013). Expression of Vpu and CD4
by transient transfection showed dramatic decreases in CD4 levels,
and CD4 depletion was dependent on serines 52 and 56 in Vpu
(Magadán et al., 2010).
Vpu-induced CD4 degradation has been shown to involve
the ERAD system. Knockdown of both β-TrCP1 and β-TrCP2
largely prevented Vpu-mediated CD4 loss (Magadán et al., 2010).
β-TrCP1 and β-TrCP2 (also known as FBW1A, FBXW1, FBXW1A,
or FWD1) are F-box proteins containing WD40 domains, which
are associated with the SCF family of ubiquitin ligases (Figure 3).
These protein complexes are linked to regulation of multiple path-
ways involving cell cycle checkpoints, NFκB, andWnt (Skaar et al.,
2013). In addition, knockdown of p97, UFD1L (also called Ufd1)
or NPL4 (see Figure 1C) blocked depletion of CD4 (Magadán
et al., 2010). Mutations that prevented ATP binding or hydrolysis
by p97 failed to affect CD4 levels (Magadán et al., 2010). These
experiments indicated that Vpu uses ERAD to degrade CD4, but
also prevents cell surface expression by retaining CD4 in the ER,
probably through transmembrane domain interactions (Maga-
dán et al., 2010). Moreover, Vpu used an atypical E3 ligase to
induce ERAD (Margottin et al., 1998), and this process involved
SCFβ−TrCP ubiquitination of the CD4 cytosolic tail on lysine, ser-
ine, and threonine residues (Magadán et al., 2010). Thus,Vpu may
act as an adapter between CD4, retrotranslocon components, and
a cytosolic E3 ligase. CD4 degradation promotes HIV-1 infection
by preventing re-infection, facilitating virus release by avoiding
Env–CD4 interactions during their trafﬁcking to the cell surface,
and minimizing adaptive immune responses (Lanzavecchia et al.,
1988; Willey et al., 1992; Argañaraz et al., 2003).
HIV-1 Vpu also targets another cellular protein, tetherin/BST-
2, for ERAD (Neil et al., 2008; Mangeat et al., 2009). Tetherin
is an unusual type II membrane protein with an N-terminal
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FIGURE 3 | Proteasomal targeting of CD4 by HIV-1Vpu.The
transmembrane protein Vpu recruits the E3 ligase complex SCFβ−TrCP.
Knockdown of both β-TrCP1 and β-TrCP1 (shown to be contacting Vpu) can
prevent CD4 degradation, suggesting that either F-box protein can provide a
functional SCF complex for ubiquitination (Magadán et al., 2010). Another
E3 ligase (E3?) also may be involved. The p97 ATPase with the adapters
Ufd1 and Npl4 are required for CD4 degradation, but the UFD1L protein
recognizes polyubiquitinated CD4. Lysine and serine/threonine residues in
the CD4 cytosolic tail are needed for ubiquitination (Magadán et al., 2010).
transmembrane segment and a C-terminal GPI anchor (Kupzig
et al., 2003; Sauter, 2014). Moreover, two tetherin monomers are
bound together by disulﬁde bonds (Ishikawa et al., 1995; Kupzig
et al., 2003). Using a unique method that only allows biotiny-
lation of retrotranslocated molecules by cytosolic BirA protein,
recent experiments indicate that both CD4 and tetherin remain
glycosylated and retain disulﬁde bonds during retrotranslocation
(Petris et al., 2014). These data suggest that the typical Sec61
channel used for translocation is insufﬁciently wide to accommo-
date retrotranslocation substrates modiﬁed with these structures
(Petris et al., 2014), but an alternativemodel involving lipid droplet
formation has not been conﬁrmed (Olzmann and Kopito, 2011).
Given the large number of proteins that have been implicated, a
single mechanism for retrotranslocation is unlikely. Despite com-
mon delivery of substrates to the proteasome via the p97 ATPase,
each of the previous examples of viral ERAD targeting involves
different E3 ligases.
Recent evidence suggests that ERAD can target the retrovirus
HIV-1 Env (Zhou et al., 2014), a glycosylated transmembrane
protein. Studies of a human CD4+ T-cell line CEM.NKR indi-
cated that HIV-1 replication is restricted in these cells, which
also are resistant to natural killer cell-mediated lysis (Howell
et al., 1985). Surprisingly, these cells overexpressed a mitochon-
drial translocator protein, TSPO (Braestrup and Squires, 1977;
Papadopoulos et al., 2006), and knockdown or knockout of this
protein rescued Env and HIV-1 production (Zhou et al., 2014).
Further experiments indicated that drugs inducing ERAD led
to recovery of Env levels and viral titers. These results sug-
gested that the ER and mitochondria communicate through
juxtaposition of their membranes, so that conditions in the mito-
chondria inﬂuence protein folding and ERAD. In support of
this conclusion, gp78 is an ERAD-associated E3 ligase (Fang
et al., 2001) localized to mitochondria–ER membrane contacts
(Fu et al., 2013). Thus, mitochondria proteins may inﬂuence
ERAD and modulate HIV-1 Env presentation to the immune
system.
Triggering of an innate immune response to viruses is affected
by the ERAD process. Some anti-viral signaling is controlled
throughmitochondria, which also cooperates with the ER for lipid
synthesis and calcium-controlled processes at the mitochondrial-
associated membrane (MAM; Jacobs et al., 2014). Mitochondrial
antiviral signaling protein (MAVS; also called IPS-1, VISA, or
CARDIF) binds to different retinoic acid-inducible gene-I (RIG-
I)-like receptor (RLR) proteins, which sense cytosolic viral RNAs
(Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al.,
2005). The MAVS protein is present in the mitochondrial and
peroxisomal membranes, and viral RNA triggers both interferon-
dependent or independent responses, respectively, (Jacobs and
Coyne, 2013; Jacobs et al., 2014). The levels of MAVS are affected
by gp78, an E3 ubiquitin ligase that is localized to the ER-
mitochondrial interface (MAM; Jacobs et al., 2014). The gp78
ligase was detected by a high throughput RNAi screen to iden-
tify genes that restricted enterovirus replication (Coyne et al.,
2011). Downregulation of gp78 was shown to decrease yields of
vesicular stomatitis virus (VSV) and to increase type I interferon
responses.
Some viruses, such as those inducing hepatitis B (HBV) or C
(HCV), use ERAD to reduce the amounts of glycoproteins and
particles produced. Interestingly, both viruses partially induce
the unfolded protein response (UPR; Li et al., 2007, 2011; Saeed
et al., 2011), which then increases the levels of certain ERAD
components. HBV, a member of the Hepadnaviridae, triggers
upregulation of the glycoside hydrolase 47 family enzymes, EDEM
1 and 2. Increased EDEM levels appear to bypass normal ER fold-
ing of HBV glycoproteins to result in ERAD (Lazar et al., 2012).
HCV, a member of the Flaviviridae, induces primarily EDEM1
through the UPR and splicing of X-box binding protein 1. Fur-
ther experiments suggested that elevated levels of EDEM 1 and
3 increase binding to SEL1L, an adapter to the retrotranslocon
(Figure 1). Inhibition of EDEM binding to SEL1L interfered
with ubiquitination of HCV Env protein, E2 (Saeed et al., 2011).
Interestingly, infections by another member of the Flaviviridae,
Japanese encephalitis virus, did not result in EDEM binding to
the Env proteins, indicating that not all viral family members
control Env proteins by this mechanism. Overall, manipulation
of EDEM levels appears to be a common mechanism to reduce
viral glycoprotein levels. Lowered amounts of Env proteins and
virus particles then contribute to avoidance of innate and adaptive
immunity, leading to chronic infections (Saeed et al., 2011; Lazar
et al., 2012).
VIRAL ESCAPE FROM ERAD
A number of pathogens harness the ERAD process to facilitate
various replication strategies. The best known examples are the
bacterial AB toxins, particularly cholera toxin, which is thought
to hijack the ERAD machinery for delivery to the cytosol (Hazes
and Read, 1997). Cholera toxin has a catalytic A chain divided
into two subunits (CTA1 and CTA2) inside a pore composed of
ﬁve receptor-binding B subunits (Spangler, 1992). The holotoxin
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binds to the ganglioside GM1 on the surface of gut epithelial cells,
which then triggers toxin internalization and trafﬁcking through
the Golgi to the ER (Fujinaga et al., 2003). The A subunits are
bound to the B subunits by disulﬁde bonds, and the toxin com-
plex interactswith the ER-resident enzymePDI (Figure 1). PDI is a
redox-dependent chaperone that unfolds the toxin, which is then
released in the oxidized state (Tsai et al., 2001). This unfolding
event appears to be required for the ability of CTA1 to retro-
translocate to the cytosol, where it induces the ADP-ribosylation
of the Gαs protein and, ultimately, opening of chloride channels
leading to massive diarrhea (Muanprasat and Chatsudthipong,
2013).
As noted above, retrotranslocation of ERAD substrates is pre-
ceded by a recognition step. The chaperone BiP, which is known
to be involved in identiﬁcation of non-glycosylated ERAD sub-
strates, and an ER-resident ATPase (Torsin A) promote CTA1
retrotranslocation (Tsai et al., 2001; Winkeler et al., 2003; Forster
et al., 2006;Moore et al., 2010). Sel1L andERdj5, a co-chaperone of
BiP, also facilitate CTA1 retrotranslocation, where the J domain of
ERdj5 is required (Williams et al., 2013). ERdj5 also binds to Sel1L,
likely providing interaction with the Hrd1 E3 ligase (see Figure 1).
Torsin A may provide the link to the membrane-resident Derlin-
1 protein (Nery et al., 2011). CTA1 retrotranslocation appears
to involve Derlin-1 (Bernardi et al., 2008) and the transmem-
brane ubiquitin ligases, Hrd1 and gp78 (Bernardi et al., 2010).
Thus, multiple low afﬁnity interactions are likely involved in
the identiﬁcation of CTA1 as a substrate and its delivery to the
retrotranslocon.
Similar to other retrotranslocated substrates, the cytosolic
p97 ATPase participates in CTA1 extraction from the ER mem-
brane (Abujarour et al., 2005; Kothe et al., 2005). Nevertheless,
CTA1 subverts the normal ERAD process by avoiding polyubiq-
uitination (Rodighiero et al., 2002). The hypothesis that CTA1
avoids ubiquitination through the absence of lysines targeted for
polyubiquitination was not substantiated by mutational analysis
(Rodighiero et al., 2002). These results indicate that CTA1 employs
many of the typical components used for ERAD targeting, includ-
ing the E3 ligase, but it is unclear how polyubiquitination and
degradation of the substrate are avoided. Therefore, retrotranslo-
con targeting and substrate extraction from the ER membrane is
not necessarily coupled to ubiquitination, althoughubiquitination
may be required for proteasomal degradation.
Viral pathogens also use ERAD. Mouse mammary tumor virus
(MMTV) is a betaretrovirus that subverts the ERAD process to
complete its viral replication cycle. All retroviruses synthesize
an unspliced viral RNA that requires export from the nucleus
to the cytosol for translation or packaging into virus particles
(Cullen, 2003). The unspliced RNAs of simple retroviruses have
a highly structured cis-acting sequence, such as the constitutive
transport element (CTE) of Mason-Pﬁzer monkey virus (MPMV;
Bray et al., 1994). The CTE facilitates RNA export through the
typical TAP/NXF1-mediated pathway used by cellular mRNAs
(Grüter et al., 1998). In contrast, the complex retroviruses encode
an adapter protein, such as the Rev protein of HIV-1 (Hanly et al.,
1989), which binds to a structured RNA element near the 3′ end
of the genome (Daly et al., 1989; Zapp and Green, 1989). MMTV
also produces aRev-like protein,Rem, for export of unsplicedRNA
(Mertz et al., 2005), but Rem binding to viral RNA has additional
translation-associated functions (Mertz et al., 2009b).
Unlike other complex retroviruses, Rem is made from an inter-
nally deleted form of the Env protein, and the export function
resides in a long SP of 98 amino acids (Indik et al., 2005; Mertz
et al., 2005). Interestingly, Rem is a precursor protein that is
directed to the ER membrane for translation, where it appears
to be cleaved by signal peptidase into the Rev-like Rem-SP and a
C-terminal glycosylated product (Rem-CT) of unknown activity
(Byun et al., 2010). Recent evidence indicates that Rem-SP uses
retrotranslocation for extraction from the ER membrane, but, like
cholera toxin, avoids proteasomal degradation (Byun et al., 2010,
2012).
Dultz et al. (2008) ﬁrst reported that Rem is directed to the
ER membrane for translation and cleavage by signal peptidase.
They also suggested that the Rem precursor (the uncleaved pro-
tein) could be detected in the nucleus by ﬂuorescence microscopy
(Dultz et al., 2008). Byun et al. (2010) showed that mutation of the
predicted signal peptidase cleavage site prevented the appearance
of Rem-SP as detected by both Western blotting and a highly sen-
sitive reporter assay for Rev-like function (Mertz et al., 2005; Byun
et al., 2010). This assay requires binding to a speciﬁc RNA element
in viral RNA (Müllner et al., 2008; Mertz et al., 2009a). Fluores-
cence experiments indicated that only the cleaved Rem-SP enters
the nucleus, whereas the uncleaved form was highly unstable and
localized to the cytosol (Byun et al., 2010). Furthermore, Rem-
SP activity was inhibited by expression of a dominant-negative
form of the p97 ATPase required for retrotranslocation (Byun
et al., 2010). Rem-SP function also was reduced by the expres-
sion of a dominant-negative Derlin-1, but not Derlin-2 protein
(Byun et al., in preparation). These results strongly suggest that
Rem must be cleaved by signal peptidase prior to SP retrotranslo-
cation to the cytosol and import into the nucleus for RNA binding
(Figure 4).
Experiments indicate that an altered conformation of either the
N-terminal Rem-SP in the cytosol or the ER-luminal portion of
Rem affect folding and accessibility to signal peptidase, which is
associated with translocons (Falk and Gilula, 1998). First, Rem
tagging at the C-terminus with green ﬂuorescent protein (Rem-
GFP) resulted in a stable protein that was inefﬁciently cleaved
and had little ﬂuorescence (Mertz et al., 2005; Byun et al., 2012).
Rem-GFP also had very low functional activity in reporter assays
(Mertz et al., 2005). In contrast, Rem tagged at the N-terminus
with GFP was cleaved normally, and GFP-Rem-SP localized to
the nucleoli, a result typical of other Rev-like proteins (Cullen,
2003; Mertz et al., 2005). Second, deletion mutations of the Rem
C-terminus greatly affected stability of the protein (Byun et al.,
2012). Removal of the 50 C-terminal amino acids had little effect
on the cleavage or stability of the protein, but deletion of 100
or 150 amino acids produced a highly unstable precursor that
could be rescued by the proteasomal inhibitor MG-132 (Byun
et al., 2012). Reduced cleavage of the precursor also was observed.
Surprisingly, further deletion to give only the SP (Rem-SP) again
yielded a stable protein (Byun et al., 2012). Third, substitution of
the leucine at position 71 in the SP gave a stable precursor protein
that was poorly cleaved by signal peptidase (Mertz et al., 2009a;
Byun et al., 2010). An independent report indicated that residues
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FIGURE 4 |Trafficking of the MMTV Rem protein by subversion of ERAD.
Rem is a precursor protein that has an N-terminal signal peptide (Rem-SP)
that directs translation to the ER membrane. The Rem-CT enters the ER
lumen, where it is modiﬁed by N-glycosylation on two different sites. Rem
recognition for retrotranslocation is not understood, but appears to involve
Derlin-1 and, potentially, an E3 ligase, although ubiquitinated Rem has not
been observed. Full-length Rem is cleaved by signal peptidase, and Rem-CT
is released into the ER lumen. Similar to other retrotranslocation substrates,
Rem-SP is extracted from the ER membrane using the p97 ATPase. Despite
its dislocation into the cytosol, Rem-SP escapes the proteasome and
translocates into the nucleus for binding of MMTV RNA.This ﬁgure is adapted
from Byun et al. (2012).
80 through 98 act as the hydrophobic membrane anchor sequence,
suggesting that position 71 is localized in the cytosol (Dultz et al.,
2008). Recognition of RemC-terminal sequences in the ER lumen,
presumably by their interaction or lack of interaction with speciﬁc
chaperone proteins, prevent degradation by ERAD.
The ER-luminal chaperone BiP has repeatedly been detected
after puriﬁcation and proteomic analysis of Rem-binding pro-
teins (Gou et al., manuscript in preparation). Our preliminary
data indicate that Rem-SP is not ubiquitinated, and it is possible
that this feature protects Rem-SP from proteasomal degradation.
Since the Rem precursor and C-terminal deletion mutants are
subject to ERAD, cleavage and association with speciﬁc cellular
proteins appear to be critical for avoidance of the degradative pro-
cess. The idea that viral proteins manipulate E3 enzymes to form
alternative complexes (Olzmann et al., 2013) would be consistent
with Rem-SP escape from ERAD.
The polyomaviruses have a unique entry method that uses
retrotranslocation, while avoiding ERAD. The BK polyomavirus
(BKV) ﬁrst binds to the ganglioside receptors GT1b and GD1b
and enters through caveolae (Neu et al., 2009), which are com-
posed of membrane microdomains/lipid rafts that are enriched
for sphingolipids and signaling molecules (Head et al., 2014;
Figure 5). Particle delivery to the cytosol occurs through a pH-
dependent step involving endosomal trafﬁcking via microtubules
to the ER (Eash and Atwood, 2005; Moriyama and Sorokin, 2008;
Jiang et al., 2009). Other members of the Polyomaviridae use
caveolae-independent entry for ER delivery (Neu et al., 2009).
ER localization of these viruses is necessary to access speciﬁc
retrotranslocation components.
The VP1 capsid proteins of polyomaviruses form pentamers
during assembly that are held together by disulﬁde bonding (Li
et al., 2003). Each pentamer is associated with one molecule of
either the minor capsid protein VP2 or VP3 (Barouch and Harri-
son, 1994), which become accessible to antibodies after exposure
to the unique environment of the ER (Norkin et al., 2002). Par-
ticle delivery into the ER allows reduction and isomerization of
disulﬁde bonds using ERp29 (mouse polyomavirus; Magnuson
et al., 2005) or ERp57 and PDI (SV40; Schelhaas et al., 2007) to
allow partial uncoating (Jiang et al., 2009; Tsai and Qian, 2010).
The partially uncoated virion then engages the retrotranslocation
machinery to allow cytosolic entry similar to cholera toxin (Neu
et al., 2009).
Interestingly, different polyomaviruses use distinct Derlin fam-
ily members for retrotranslocation. SV40 uses Derlin-1 and SEL1L
(Schelhaas et al., 2007), whereasmouse polyoma virus usesDerlin-
2 (Lilley et al., 2006; Figure 5). Additional experiments indicate
that exposure of VP2 hydrophobic sequences tethers virus par-
ticles to the ER membrane, and that both BiP and BAP31 are
needed for dislocation of SV40 to the cytosol (Geiger et al., 2011).
BAP31 may serve as a shuttle to the ERQC that has been asso-
ciated with enriched ERAD components (Kamhi-Nesher et al.,
2001; Wakana et al., 2008). Furthermore, use of epoxomicin or
eeyarestatin 1, inhibitors of the proteasome or p97ATPase, respec-
tively, blocked early events of BKV infection (Bennett et al., 2013).
Epoxomicin treatment of cells allowed accumulation of BKV in the
calnexin-rich, BiP-deﬁcient ERQC (Bennett et al., 2013). These
results are consistent with ERAD extraction of polyomaviruses
from the ER to the cytosol, although it is has been suggested that
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FIGURE 5 | Use of ERAD for polyomavirus uncoating. Many
polyomaviruses enter through caveosomes that are enriched for viral entry
receptors, triggering particle uptake through endosomes. Using the
microtubule network, vesicles trafﬁc the virus to the ER, where the unique
environment allows structural changes to the icosahedral capsids. Studies of
JCV, BKV, and SV40 indicate that viral particles interact with PDI and ERp57 in
the ER lumen to rearrange capsid proteins. In contrast, the related mouse
polyomavirus (PyV) uses the PDI family member, ERp29, presumably for a
similar function. The altered particles then appear to engage different
retrotranslocons (dependent on either Derlin-1 or Derlin-2) to induce
retrotranslocation to the cytosol, where the reduced calcium environment
produces further capsid rearrangements. These particles then bind to the
nuclear pore where uncoating occurs to allow passage of viral DNA into the
nucleus. This ﬁgure is adapted from Neu et al. (2009).
there are cell-type and virus-speciﬁc differences and that direct
ER to nuclear transport may occur (Bennett et al., 2013). Low
levels of calcium in the cytosol lead to further capsid destabiliza-
tion and exposure of the nuclear localization signals on capsid
proteins. The partially uncoated capsid then transits through the
nuclear pores for initiation of viral DNA replication (Neu et al.,
2009).
The preceding experiments indicate that ERAD is used by
viruses to allow trafﬁcking events that promote replication.
MMTV Rem trafﬁcking through the ER allows access to signal
peptidase and cleavage of Rem precursor into functional N- and
C-terminal proteins. In contrast, the polyomaviruses use ERAD
to partially uncoat virions on their path to the nucleus. Impor-
tantly, both types of viruses avoid proteasomal degradation during
ERAD, although the mechanisms remain unclear.
VIRUSES AND ERAD TUNING
ERAD may be regulated or “tuned” through the rapid turnover
of speciﬁc components through the proteasomes or autophago-
somes/vesicular trafﬁcking to lysosomes (Merulla et al., 2013).
Normal secretory vesicles released from the ER are 60–70 nm in
diameter and have coatamer proteins, such as COPII, whereas the
ER-derived tuning vesicles (EDEMosomes) lack coatamers and are
200–800 nm in diameter (Bernasconi et al., 2012b). Tuning vesi-
cles contain SEL1L, EDEM1, and OS-9, which are transmembrane
or luminal proteins involved in ERAD (Figure 1; Olzmann et al.,
2013). EDEMosomes are believed to reduce ERAD by disposal
in acidic organelles (Bernasconi et al., 2012b), favoring the cor-
rect folding of polypeptides (Calì et al., 2008). The coronaviruses
are known to take advantage of ERAD tuning (Reggiori et al.,
2010).
Many plus-stranded RNA-containing viruses manipulate cel-
lular membranes to further RNA replication (Paul and Barten-
schlager, 2013). These membrane structures have been divided
into invaginated vesicle/spherule type anddouble-membrane vesi-
cle (DMV) type (two lipid bilayers). Such vesicles allow viruses to
concentrate their replication components, to separate distinct viral
processes (e.g., translation, transcription, and replication), and to
avoid immune detection (Paul and Bartenschlager, 2013). Severe
acute respiratory syndrome coronavirus (SARS-CoV) and mouse
hepatitis virus (MHV) induce DMVs for targeting their replica-
tion and transcription (Reggiori et al., 2010). The DMVs originate
from ER membranes and contain the non-structural transmem-
brane proteins nsp3 and nsp4 and viral double-stranded RNA
(Stertz et al., 2007; Reggiori et al., 2010). Nevertheless, DMVs lack
markers typical of the ERGIC or the Golgi (Oostra et al., 2007).
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Recent experiments indicate that DMVs are coated with
microtubule-associated protein light chain 3 [LC3; Atg8 in yeast
(Reggiori et al., 2010)], which is a ubiquitin-like modiﬁer (van der
Veen and Ploegh, 2012). LC3 can exist in a lipidated form (cova-
lent linkage to phosphatidylethanolamine; also known as LC3-II)
or a predominantly cytosolic non-lipidated form(LC3-I). LC3-II is
believed to be involved in fusion of autophagosomes to lysosomes
(van der Veen and Ploegh, 2012), but coronavirus DMVs display
the non-lipidated LC3-I (Reggiori et al., 2010). These ubiquitin-
like modiﬁers recognize speciﬁc receptors that target associated
vesicles to particular cellular locations (van der Veen and Ploegh,
2012). The coronaviruses appear to be redirecting vesicles destined
for autophagosomes to sequestered locations in the cytosol where
replication will occur.
The autophagymachinery is not required for coronavirus repli-
cation, and no colocalization of viral non-structural proteins
was observed with LC3-II-coated autophagosomes (Reggiori et al.,
2010). Coronavirus-induced DMVs and EDEMosomes both are
coated with the non-lipidated LC3-I protein (Calì et al., 2008;
Reggiori et al., 2010), which is not covalently attached to mem-
branes like LC3-II (Kabeya et al., 2000). Induction of autophagy
in coronavirus-infected cells with rapamycin decreased the levels
of EDEM1 and coronavirus (Reggiori et al., 2010). The virus-
containing DMVs had both EDEM1 and OS-9, but not other
ERAD-associated chaperones, and virus infection interfered with
ERAD tuning by hijacking the EDEMosomes. Nevertheless, LC3-I,
but not EDEM1 and OS-9, is necessary for coronavirus infec-
tion, and the hijacked EDEMosome cargo is not degraded by
proteases in the endosomes/lysosomes (Reggiori et al., 2010). Fur-
ther, the ERAD transmembrane adapter protein, SEL1L, is needed
for DMV formation, capturing the ER-resident EDEM1 and OS-
9 proteins (and possibly XTP3-B and EDEM3), while using its
proline-rich cytosolic domain to bind to LC3-I. As expected,
SEL1L knockdown impairs coronavirus replication (Bernasconi
et al., 2012a).
The organizationally similar arterioviruses (classiﬁed with
coronaviruses, toroviruses, and roniviruses into the order Nidovi-
rales; Gorbalenya et al., 2006) subvert EDEMosome trafﬁcking
for their replication, although the size of the vesicles is smaller
(Monastyrska et al., 2013). The mechanism for altering EDEM1-
containing vesicular trafﬁcking is unclear, but likely involves
expression of viral non-structural proteins that span the ER-
derived membranes (Monastyrska et al., 2013), perhaps through
their interaction with SEL1L. These experiments indicate that
viruses hijack EDEMosomes to sequester their double-stranded
RNA from cytosolic sensors that will trigger interferon produc-
tion and innate immunity (Zinzula andTramontano, 2013). Other
components of the ERAD system, particularly chaperone proteins,
also participate in the replication and transmission of both plant
and mammalian viruses (Verchot, 2014).
CONCLUSION
The ERAD system is a complex and highly regulated process
controlling the disposal of misfolded or misassembled proteins
that are directed to the ER for translation. Deregulation of this
process results in pathogenic conditions, including infectious dis-
eases. Viruses exploit ERAD to decrease overall viral levels and
allow establishment of chronic infections by minimizing antigen
presentation to the immune system. Trafﬁcking of speciﬁc viral
proteins or entire virion particles may involve ERAD for refold-
ing or processing in the unique ER environment. Alternatively,
viruses can use ERAD-associated components to form isolated
lipid vesicles for replication and shelter from immune detection.
Virus-mediated subversion of ERAD can lead to degradation of
molecules that are involved in innate or adaptive immunity. Con-
tinued studies of viruses are certain to provide additional insights
into both the ERAD process and the components that regulate it.
Further experiments may identify targets for viral therapeutics.
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